Intravenous rt-PA versus endovascular therapy for acute ischemic stroke

Current Atherosclerosis Reports

Volumn 10, Issue 4, 2008, Pages 332-338

  Mandava, Pitchaiah ^b   Suarez, Jose I ^b   Kent, Thomas A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; MORTALITY; OUTCOME ASSESSMENT; REVIEW; TREATMENT DURATION;

BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; RECOMBINANT PROTEINS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 58649103489     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-008-0051-x     Document Type: Review

References (70)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333: 1581-1587.
2. The Third International Stroke Trial (Thrombolysis). Available at http://www.dcn.ed.ac.uk/ist3. Accessed March 6, 2008.
3. ECASS 3 - The European Cooperative Acute Stroke Study. Available at http://www.ecass3.com. Accessed March 7, 2008.
4. Davis SM, Donnan GA, Parsons MW, et al.: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 2008, 7: 299-309.
5. Lees KR, Zivin JA, Ashwood T, et al.: NXY-059 for acute ischemic stroke. N Engl J Med 2006, 354: 588-600.
6. Shuaib A, Lees KR, Lyden P, et al.: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007, 357: 562-571.
7. Clark WM, Coull BM, Karukin M, et al.: Randomized trial of cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke. J Stroke Cerebrovasc Dis 1996, 6: 35-40.
8. Clark WM, Raps EC, Tong DC, Kelly RE: Cervene (nalmefene) in acute ischemic stroke: Final results of a phase III efficacy study. The Cervene Stroke Study Investigators. Stroke 2000, 31: 1234-1239.
9. McDougall C, Clark W,SMayer T, et al.: The Penumbra Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in acute ischemic stroke. Paper presented at the International Stroke Conference. New Orleans, LA; February 22, 2008.
10. GobAn YP, Starkman S, Duckwiler GR, et al.: MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004, 35: 2848-2854.
11. Interventional Management of Stroke III. Available at http://www.ims3.org. Accessed March 7, 2008.
12. deA Zoppo GJ, Higashida RT, Furlan AJ, et al.: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998, 29: 4-11.
13. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: A randomized controlled trial. JAMA 1999, 282: 2003-2011.
14. Uchino K, Billheimer D, Cramer SC: Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke 2001, 32: 909-916.
15. Weimar C, Konig IR, Kraywinkel K, et al.: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: Development and external validation of prognostic models. Stroke 2004, 35: 158-162.
16. Adams HP Jr, Davis PH, Leira EC, et al.: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53: 126-131.
17. Mandava P, Kent TA: Intra-arterial therapies for acute ischemic stroke. Neurology 2007, 68: 2132-2139.
18. Mandava P, Kent TA: A method to predict stroke trial success based on pooled control arms [abstract 20]. Paper presented at International Stroke Conference. New Orleans, LA; February 22, 2008. Available at http://stroke.ahajournals.org/cgi/reprint/39/2/527.
19. Zar JH: Biostatistical Analysis, edn 3. Upper Saddle River, NJ: Prentice-Hall; 1996:282-283.
20. Beers KJ: Numerical Methods for Chemical Engineering. Applications in Matlab. Cambridge, UK: Cambridge University Press; 2007:81-85 and 225-230.
21. Mangiafico S, Cellerini M, Nencini P, et al.: Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intraarterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005, 26: 2595-2601.
22. Sterne JA, Egger M, Smith GD: Investigating and dealing with publication and other biases in metaanalysis. BMJ 2001, 323: 101-105.
23. Hacke W, Kaste M, Fieschi C, et al.: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363: 768-774.
24. Alexandrov AV, Molina CA, Grotta JC, et al.: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351: 2170-2178.
25. Mori E, Tabuchi M, Yoshida T, Yamadori A: Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988, 19: 802-812.
26. Ezura M, Kagawa S: Selective and superselective infusion of urokinase for embolic stroke. Surg Neurol 1992, 38: 353-358.
27. Ogawa A, Mori E, Minematsu K, et al.: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007, 38: 2633-2639.
28. Adams HP, Leclerc JR, Bluhmki E, et al.: Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004, 18: 124-129.
29. Quast MJ, Huang NC, Hillman GR, Kent TA: The evolution of acute stroke recorded by multimodal magnetic resonance imaging. Magn Reson Imaging 1993, 11: 465-471.
30. Albers GW, Thijs VN, Wechsler L, et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60: 508-517.
31. Becker KJ, Brott TG: Approval ofAthe MERCI clot retriever: a critical view. Stroke 2005, 36: 400-403.
32. Wechsler LR: Does the Merci Retriever work? Against. Stroke 2006, 37: 1341-1342.
33. Ciccone A, Valvassori L, Gasparotti R, et al.: Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 2007, 38: 2191-2195.
34. Pancioli AM: The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (the CLEAR Stroke Trial): Final results from Tier I and II [abstract 15]. Paper presented at International Stroke Conference. New Orleans LA; February 22, 2008. Available at http://stroke.ahajournals.org/cgi/reprint/39/2/527.
35. Mandava P, Thiagarajan P, Kent TA: GP IIB/IIIa inhibitors in acute ischemic stroke: Current status and future directions. Drugs 2008 (in press).
36. Lo EH, Broderick JP, Moskowitz MA: TPA and proteolysis in the neurovascular unit. Stroke 2004, 35: 354-356.
37. Fischer U, Arnold M, Nedeltchev K, et al.: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005, 36: 2121-2125.
38. Walton M; Food and Drug Administration Division of Clinical Trial Design and Analysis: Clinical review for PLA 96-350. Available at http://www.fda.gov/cder/biologics/review/altegen061896r2.pdf. Accessed January 24, 2008.
39. Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30: 2598-2605.
40. Bourekas EC, Slivka AP, Shah R, et al.: Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery 2004, 54: 39-44.
41. Sekoranja L, Loulidi J, Yilmaz H, et al.: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke. A transcranial color-coded duplex sonography-guided pilot study. Stroke 2006, 37: 1805-1809.
42. Zaidat OO, Slivka AP, Mohammed Y, et al.: Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. Stroke 2005, 36: 1089-1090.
43. Kim DJ, Kim DI, Kim SH, et al.: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005, 47: 616-621.
44. Flaherty ML, Woo D, Kissela B, et al.: Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005, 64: 386-388.
45. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 2004, 35: 904-911.
46. IMS II Trial Investigators: The interventional management of stroke (IMS) II Study. Stroke 2007, 38: 2127-2135.
47. Lee KY, Kim DI, Kim SH, et al.: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004, 25: 1470-1475.
48. Clark WM, Albers GW, Madden KP, Hamilton S: The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276g): Results of a double-blind, placebo-controlled, multicenter study: Thrombolytic Therapy in Acute Ischemic Stroke Study investigators. Stroke 2000, 31: 811-816.
49. Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352: 1245-1251.
50. Hu HH, Teng MM, Hsu L, et al.: A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window. Stroke 2006, 37: 918-919.
51. Arnold M, Schroth G, Nedeltchev K, et al.: Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002, 33: 1828-1833.
52. Zaidat OO, Suarez JI, Santillan C, et al.: Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002, 33: 1821-1826.
53. Lee DH, Jo KD, Kim HG, et al.: Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: A pilot study. J Vasc Interv Radiol 2002, 13: 769-774.
54. Nakano S, Iseda T, Yoneyama T, et al.: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: An alternative option to intra-arterial thrombolysis. Stroke 2002, 33: 2872-2876.
55. Ueda T, Sakaki S, Kumon Y, Ohta S: Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30: 2360-2365.
56. Arnold M, Nedeltchev K, Mattle HP, et al.: Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions. J Neurol Neurosurg Psychiatry 2003, 74: 739-742.
57. Jahan R, Duckwiler GR, Kidwell CS, et al.: Intraarterial thrombolysis for treatment of acute stroke: Experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999, 20: 1291-1299.
58. Imai K, Mori T, Izumoto H, et al.: Clot removal therapy by aspiration and extraction for acute embolic carotid occlusion. AJNR Am J Neuroradiol 2005, 27: 1521-1527.
59. Qureshi AI, Siddiqui AM, Suri MF, et al.: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery 2002, 51: 1319-1327.
60. Sorimachi T, Fuji Y, Tsuchiya N, et al.: Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004, 25: 1391-1402.
61. Keris V, Rudnicka S, Vorona V, et al.: Combined intraarterial/ intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001, 22: 352-358.
62. Suarez JI, Sunshine JL, Tarr R, et al.: Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30: 2094-2100.
63. Ostrem JL, Saver JL, Alger JR, et al.: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004, 35: E30-e34.
64. Arnold M, Nedeltchev K, Schroth G, et al.: Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004, 75: 857-862.
65. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005, 36: 1432-1438.
66. Smith WS, Sung G, Saver J, et al.: Mechanical thrombectomy for acute ischemic stroke. Final results of the Multi MERCI trial. Stroke 2008, 39: 1205-1212.
67. Mahon BR, Nesbit GM, Barnwell SL, et al.: North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003, 24: 534-538.
68. Kim D, Jahan R, Starkman S, et al.: Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR Am J Neuroradiol 2006, 27: 2048-2052.
69. Bergui M, Stura G, Daniele D, et al.: Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006, 37: 145-150.
70. Eckert B, Koch C, Thomalla G, et al.: Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/ stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): Results of a multicenter study. Stroke 2005, 36: 1160-1165.